Medical Care
Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Research Report 2025
- Jan 17, 26
- ID: 677683
- Pages: 83
- Figures: 84
- Views: 13
This report aims to provide a comprehensive presentation of the global market for Peptide-Drug Conjugates(PDCs) CDMO Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide-Drug Conjugates(PDCs) CDMO Service.
The Peptide-Drug Conjugates(PDCs) CDMO Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide-Drug Conjugates(PDCs) CDMO Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide-Drug Conjugates(PDCs) CDMO Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
WUXIAPP
Medicilon
Creative Peptides
Peptistar
BOCSCI Inc
HUATENG PHARMA
CPC Scientific Inc
Porton
VIVA Biotech
Taichu Group
PharosGen
CENTER LABORATORIES, INC
JIUZHOU Pharmaceutical
Segment by Type
Therapeutic
Diagnostic
Segment by Application
SME Pharmaceutical Company
Large Pharmaceutical Company
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide-Drug Conjugates(PDCs) CDMO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Peptide-Drug Conjugates(PDCs) CDMO Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide-Drug Conjugates(PDCs) CDMO Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide-Drug Conjugates(PDCs) CDMO Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
WUXIAPP
Medicilon
Creative Peptides
Peptistar
BOCSCI Inc
HUATENG PHARMA
CPC Scientific Inc
Porton
VIVA Biotech
Taichu Group
PharosGen
CENTER LABORATORIES, INC
JIUZHOU Pharmaceutical
Segment by Type
Therapeutic
Diagnostic
Segment by Application
SME Pharmaceutical Company
Large Pharmaceutical Company
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide-Drug Conjugates(PDCs) CDMO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Therapeutic
1.2.3 Diagnostic
1.3 Market by Application
1.3.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 SME Pharmaceutical Company
1.3.3 Large Pharmaceutical Company
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Perspective (2020-2031)
2.2 Global Peptide-Drug Conjugates(PDCs) CDMO Service Growth Trends by Region
2.2.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Peptide-Drug Conjugates(PDCs) CDMO Service Historic Market Size by Region (2020-2025)
2.2.3 Peptide-Drug Conjugates(PDCs) CDMO Service Forecasted Market Size by Region (2026-2031)
2.3 Peptide-Drug Conjugates(PDCs) CDMO Service Market Dynamics
2.3.1 Peptide-Drug Conjugates(PDCs) CDMO Service Industry Trends
2.3.2 Peptide-Drug Conjugates(PDCs) CDMO Service Market Drivers
2.3.3 Peptide-Drug Conjugates(PDCs) CDMO Service Market Challenges
2.3.4 Peptide-Drug Conjugates(PDCs) CDMO Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide-Drug Conjugates(PDCs) CDMO Service Players by Revenue
3.1.1 Global Top Peptide-Drug Conjugates(PDCs) CDMO Service Players by Revenue (2020-2025)
3.1.2 Global Peptide-Drug Conjugates(PDCs) CDMO Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Peptide-Drug Conjugates(PDCs) CDMO Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peptide-Drug Conjugates(PDCs) CDMO Service Revenue
3.4 Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Concentration Ratio
3.4.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide-Drug Conjugates(PDCs) CDMO Service Revenue in 2024
3.5 Global Key Players of Peptide-Drug Conjugates(PDCs) CDMO Service Head office and Area Served
3.6 Global Key Players of Peptide-Drug Conjugates(PDCs) CDMO Service, Product and Application
3.7 Global Key Players of Peptide-Drug Conjugates(PDCs) CDMO Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide-Drug Conjugates(PDCs) CDMO Service Breakdown Data by Type
4.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Historic Market Size by Type (2020-2025)
4.2 Global Peptide-Drug Conjugates(PDCs) CDMO Service Forecasted Market Size by Type (2026-2031)
5 Peptide-Drug Conjugates(PDCs) CDMO Service Breakdown Data by Application
5.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Historic Market Size by Application (2020-2025)
5.2 Global Peptide-Drug Conjugates(PDCs) CDMO Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size (2020-2031)
6.2 North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2020-2025)
6.4 North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size (2020-2031)
7.2 Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2020-2025)
7.4 Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size (2020-2031)
8.2 Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size (2020-2031)
9.2 Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2020-2025)
9.4 Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size (2020-2031)
10.2 Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 WUXIAPP
11.1.1 WUXIAPP Company Details
11.1.2 WUXIAPP Business Overview
11.1.3 WUXIAPP Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.1.4 WUXIAPP Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.1.5 WUXIAPP Recent Development
11.2 Medicilon
11.2.1 Medicilon Company Details
11.2.2 Medicilon Business Overview
11.2.3 Medicilon Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.2.4 Medicilon Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.2.5 Medicilon Recent Development
11.3 Creative Peptides
11.3.1 Creative Peptides Company Details
11.3.2 Creative Peptides Business Overview
11.3.3 Creative Peptides Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.3.4 Creative Peptides Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.3.5 Creative Peptides Recent Development
11.4 Peptistar
11.4.1 Peptistar Company Details
11.4.2 Peptistar Business Overview
11.4.3 Peptistar Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.4.4 Peptistar Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.4.5 Peptistar Recent Development
11.5 BOCSCI Inc
11.5.1 BOCSCI Inc Company Details
11.5.2 BOCSCI Inc Business Overview
11.5.3 BOCSCI Inc Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.5.4 BOCSCI Inc Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.5.5 BOCSCI Inc Recent Development
11.6 HUATENG PHARMA
11.6.1 HUATENG PHARMA Company Details
11.6.2 HUATENG PHARMA Business Overview
11.6.3 HUATENG PHARMA Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.6.4 HUATENG PHARMA Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.6.5 HUATENG PHARMA Recent Development
11.7 CPC Scientific Inc
11.7.1 CPC Scientific Inc Company Details
11.7.2 CPC Scientific Inc Business Overview
11.7.3 CPC Scientific Inc Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.7.4 CPC Scientific Inc Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.7.5 CPC Scientific Inc Recent Development
11.8 Porton
11.8.1 Porton Company Details
11.8.2 Porton Business Overview
11.8.3 Porton Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.8.4 Porton Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.8.5 Porton Recent Development
11.9 VIVA Biotech
11.9.1 VIVA Biotech Company Details
11.9.2 VIVA Biotech Business Overview
11.9.3 VIVA Biotech Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.9.4 VIVA Biotech Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.9.5 VIVA Biotech Recent Development
11.10 Taichu Group
11.10.1 Taichu Group Company Details
11.10.2 Taichu Group Business Overview
11.10.3 Taichu Group Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.10.4 Taichu Group Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.10.5 Taichu Group Recent Development
11.11 PharosGen
11.11.1 PharosGen Company Details
11.11.2 PharosGen Business Overview
11.11.3 PharosGen Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.11.4 PharosGen Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.11.5 PharosGen Recent Development
11.12 CENTER LABORATORIES, INC
11.12.1 CENTER LABORATORIES, INC Company Details
11.12.2 CENTER LABORATORIES, INC Business Overview
11.12.3 CENTER LABORATORIES, INC Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.12.4 CENTER LABORATORIES, INC Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.12.5 CENTER LABORATORIES, INC Recent Development
11.13 JIUZHOU Pharmaceutical
11.13.1 JIUZHOU Pharmaceutical Company Details
11.13.2 JIUZHOU Pharmaceutical Business Overview
11.13.3 JIUZHOU Pharmaceutical Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.13.4 JIUZHOU Pharmaceutical Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.13.5 JIUZHOU Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Therapeutic
1.2.3 Diagnostic
1.3 Market by Application
1.3.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 SME Pharmaceutical Company
1.3.3 Large Pharmaceutical Company
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Perspective (2020-2031)
2.2 Global Peptide-Drug Conjugates(PDCs) CDMO Service Growth Trends by Region
2.2.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Peptide-Drug Conjugates(PDCs) CDMO Service Historic Market Size by Region (2020-2025)
2.2.3 Peptide-Drug Conjugates(PDCs) CDMO Service Forecasted Market Size by Region (2026-2031)
2.3 Peptide-Drug Conjugates(PDCs) CDMO Service Market Dynamics
2.3.1 Peptide-Drug Conjugates(PDCs) CDMO Service Industry Trends
2.3.2 Peptide-Drug Conjugates(PDCs) CDMO Service Market Drivers
2.3.3 Peptide-Drug Conjugates(PDCs) CDMO Service Market Challenges
2.3.4 Peptide-Drug Conjugates(PDCs) CDMO Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide-Drug Conjugates(PDCs) CDMO Service Players by Revenue
3.1.1 Global Top Peptide-Drug Conjugates(PDCs) CDMO Service Players by Revenue (2020-2025)
3.1.2 Global Peptide-Drug Conjugates(PDCs) CDMO Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Peptide-Drug Conjugates(PDCs) CDMO Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peptide-Drug Conjugates(PDCs) CDMO Service Revenue
3.4 Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Concentration Ratio
3.4.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide-Drug Conjugates(PDCs) CDMO Service Revenue in 2024
3.5 Global Key Players of Peptide-Drug Conjugates(PDCs) CDMO Service Head office and Area Served
3.6 Global Key Players of Peptide-Drug Conjugates(PDCs) CDMO Service, Product and Application
3.7 Global Key Players of Peptide-Drug Conjugates(PDCs) CDMO Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide-Drug Conjugates(PDCs) CDMO Service Breakdown Data by Type
4.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Historic Market Size by Type (2020-2025)
4.2 Global Peptide-Drug Conjugates(PDCs) CDMO Service Forecasted Market Size by Type (2026-2031)
5 Peptide-Drug Conjugates(PDCs) CDMO Service Breakdown Data by Application
5.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Historic Market Size by Application (2020-2025)
5.2 Global Peptide-Drug Conjugates(PDCs) CDMO Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size (2020-2031)
6.2 North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2020-2025)
6.4 North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size (2020-2031)
7.2 Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2020-2025)
7.4 Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size (2020-2031)
8.2 Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size (2020-2031)
9.2 Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2020-2025)
9.4 Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size (2020-2031)
10.2 Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 WUXIAPP
11.1.1 WUXIAPP Company Details
11.1.2 WUXIAPP Business Overview
11.1.3 WUXIAPP Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.1.4 WUXIAPP Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.1.5 WUXIAPP Recent Development
11.2 Medicilon
11.2.1 Medicilon Company Details
11.2.2 Medicilon Business Overview
11.2.3 Medicilon Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.2.4 Medicilon Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.2.5 Medicilon Recent Development
11.3 Creative Peptides
11.3.1 Creative Peptides Company Details
11.3.2 Creative Peptides Business Overview
11.3.3 Creative Peptides Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.3.4 Creative Peptides Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.3.5 Creative Peptides Recent Development
11.4 Peptistar
11.4.1 Peptistar Company Details
11.4.2 Peptistar Business Overview
11.4.3 Peptistar Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.4.4 Peptistar Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.4.5 Peptistar Recent Development
11.5 BOCSCI Inc
11.5.1 BOCSCI Inc Company Details
11.5.2 BOCSCI Inc Business Overview
11.5.3 BOCSCI Inc Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.5.4 BOCSCI Inc Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.5.5 BOCSCI Inc Recent Development
11.6 HUATENG PHARMA
11.6.1 HUATENG PHARMA Company Details
11.6.2 HUATENG PHARMA Business Overview
11.6.3 HUATENG PHARMA Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.6.4 HUATENG PHARMA Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.6.5 HUATENG PHARMA Recent Development
11.7 CPC Scientific Inc
11.7.1 CPC Scientific Inc Company Details
11.7.2 CPC Scientific Inc Business Overview
11.7.3 CPC Scientific Inc Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.7.4 CPC Scientific Inc Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.7.5 CPC Scientific Inc Recent Development
11.8 Porton
11.8.1 Porton Company Details
11.8.2 Porton Business Overview
11.8.3 Porton Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.8.4 Porton Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.8.5 Porton Recent Development
11.9 VIVA Biotech
11.9.1 VIVA Biotech Company Details
11.9.2 VIVA Biotech Business Overview
11.9.3 VIVA Biotech Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.9.4 VIVA Biotech Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.9.5 VIVA Biotech Recent Development
11.10 Taichu Group
11.10.1 Taichu Group Company Details
11.10.2 Taichu Group Business Overview
11.10.3 Taichu Group Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.10.4 Taichu Group Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.10.5 Taichu Group Recent Development
11.11 PharosGen
11.11.1 PharosGen Company Details
11.11.2 PharosGen Business Overview
11.11.3 PharosGen Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.11.4 PharosGen Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.11.5 PharosGen Recent Development
11.12 CENTER LABORATORIES, INC
11.12.1 CENTER LABORATORIES, INC Company Details
11.12.2 CENTER LABORATORIES, INC Business Overview
11.12.3 CENTER LABORATORIES, INC Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.12.4 CENTER LABORATORIES, INC Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.12.5 CENTER LABORATORIES, INC Recent Development
11.13 JIUZHOU Pharmaceutical
11.13.1 JIUZHOU Pharmaceutical Company Details
11.13.2 JIUZHOU Pharmaceutical Business Overview
11.13.3 JIUZHOU Pharmaceutical Peptide-Drug Conjugates(PDCs) CDMO Service Introduction
11.13.4 JIUZHOU Pharmaceutical Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
11.13.5 JIUZHOU Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Therapeutic
Table 3. Key Players of Diagnostic
Table 4. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Region (2020-2025)
Table 8. Global Peptide-Drug Conjugates(PDCs) CDMO Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Region (2026-2031)
Table 10. Peptide-Drug Conjugates(PDCs) CDMO Service Market Trends
Table 11. Peptide-Drug Conjugates(PDCs) CDMO Service Market Drivers
Table 12. Peptide-Drug Conjugates(PDCs) CDMO Service Market Challenges
Table 13. Peptide-Drug Conjugates(PDCs) CDMO Service Market Restraints
Table 14. Global Peptide-Drug Conjugates(PDCs) CDMO Service Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Players (2020-2025)
Table 16. Global Top Peptide-Drug Conjugates(PDCs) CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service as of 2024)
Table 17. Ranking of Global Top Peptide-Drug Conjugates(PDCs) CDMO Service Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Peptide-Drug Conjugates(PDCs) CDMO Service Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Peptide-Drug Conjugates(PDCs) CDMO Service, Headquarters and Area Served
Table 20. Global Key Players of Peptide-Drug Conjugates(PDCs) CDMO Service, Product and Application
Table 21. Global Key Players of Peptide-Drug Conjugates(PDCs) CDMO Service, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Peptide-Drug Conjugates(PDCs) CDMO Service Revenue Market Share by Type (2020-2025)
Table 25. Global Peptide-Drug Conjugates(PDCs) CDMO Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Peptide-Drug Conjugates(PDCs) CDMO Service Revenue Market Share by Type (2026-2031)
Table 27. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Peptide-Drug Conjugates(PDCs) CDMO Service Revenue Market Share by Application (2020-2025)
Table 29. Global Peptide-Drug Conjugates(PDCs) CDMO Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Peptide-Drug Conjugates(PDCs) CDMO Service Revenue Market Share by Application (2026-2031)
Table 31. North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2026-2031) & (US$ Million)
Table 46. WUXIAPP Company Details
Table 47. WUXIAPP Business Overview
Table 48. WUXIAPP Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 49. WUXIAPP Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 50. WUXIAPP Recent Development
Table 51. Medicilon Company Details
Table 52. Medicilon Business Overview
Table 53. Medicilon Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 54. Medicilon Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 55. Medicilon Recent Development
Table 56. Creative Peptides Company Details
Table 57. Creative Peptides Business Overview
Table 58. Creative Peptides Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 59. Creative Peptides Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 60. Creative Peptides Recent Development
Table 61. Peptistar Company Details
Table 62. Peptistar Business Overview
Table 63. Peptistar Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 64. Peptistar Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 65. Peptistar Recent Development
Table 66. BOCSCI Inc Company Details
Table 67. BOCSCI Inc Business Overview
Table 68. BOCSCI Inc Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 69. BOCSCI Inc Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 70. BOCSCI Inc Recent Development
Table 71. HUATENG PHARMA Company Details
Table 72. HUATENG PHARMA Business Overview
Table 73. HUATENG PHARMA Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 74. HUATENG PHARMA Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 75. HUATENG PHARMA Recent Development
Table 76. CPC Scientific Inc Company Details
Table 77. CPC Scientific Inc Business Overview
Table 78. CPC Scientific Inc Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 79. CPC Scientific Inc Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 80. CPC Scientific Inc Recent Development
Table 81. Porton Company Details
Table 82. Porton Business Overview
Table 83. Porton Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 84. Porton Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 85. Porton Recent Development
Table 86. VIVA Biotech Company Details
Table 87. VIVA Biotech Business Overview
Table 88. VIVA Biotech Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 89. VIVA Biotech Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 90. VIVA Biotech Recent Development
Table 91. Taichu Group Company Details
Table 92. Taichu Group Business Overview
Table 93. Taichu Group Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 94. Taichu Group Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 95. Taichu Group Recent Development
Table 96. PharosGen Company Details
Table 97. PharosGen Business Overview
Table 98. PharosGen Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 99. PharosGen Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 100. PharosGen Recent Development
Table 101. CENTER LABORATORIES, INC Company Details
Table 102. CENTER LABORATORIES, INC Business Overview
Table 103. CENTER LABORATORIES, INC Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 104. CENTER LABORATORIES, INC Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 105. CENTER LABORATORIES, INC Recent Development
Table 106. JIUZHOU Pharmaceutical Company Details
Table 107. JIUZHOU Pharmaceutical Business Overview
Table 108. JIUZHOU Pharmaceutical Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 109. JIUZHOU Pharmaceutical Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 110. JIUZHOU Pharmaceutical Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Peptide-Drug Conjugates(PDCs) CDMO Service Picture
Figure 2. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Type: 2024 VS 2031
Figure 4. Therapeutic Features
Figure 5. Diagnostic Features
Figure 6. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Application: 2024 VS 2031
Figure 8. SME Pharmaceutical Company Case Studies
Figure 9. Large Pharmaceutical Company Case Studies
Figure 10. Peptide-Drug Conjugates(PDCs) CDMO Service Report Years Considered
Figure 11. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Region: 2024 VS 2031
Figure 14. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Players in 2024
Figure 15. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Peptide-Drug Conjugates(PDCs) CDMO Service Revenue in 2024
Figure 17. North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Country (2020-2031)
Figure 19. United States Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Country (2020-2031)
Figure 23. Germany Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Region (2020-2031)
Figure 31. China Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Country (2020-2031)
Figure 39. Mexico Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Country (2020-2031)
Figure 43. Turkey Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. WUXIAPP Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 47. Medicilon Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 48. Creative Peptides Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 49. Peptistar Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 50. BOCSCI Inc Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 51. HUATENG PHARMA Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 52. CPC Scientific Inc Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 53. Porton Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 54. VIVA Biotech Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 55. Taichu Group Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 56. PharosGen Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 57. CENTER LABORATORIES, INC Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 58. JIUZHOU Pharmaceutical Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Therapeutic
Table 3. Key Players of Diagnostic
Table 4. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Region (2020-2025)
Table 8. Global Peptide-Drug Conjugates(PDCs) CDMO Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Region (2026-2031)
Table 10. Peptide-Drug Conjugates(PDCs) CDMO Service Market Trends
Table 11. Peptide-Drug Conjugates(PDCs) CDMO Service Market Drivers
Table 12. Peptide-Drug Conjugates(PDCs) CDMO Service Market Challenges
Table 13. Peptide-Drug Conjugates(PDCs) CDMO Service Market Restraints
Table 14. Global Peptide-Drug Conjugates(PDCs) CDMO Service Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Players (2020-2025)
Table 16. Global Top Peptide-Drug Conjugates(PDCs) CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service as of 2024)
Table 17. Ranking of Global Top Peptide-Drug Conjugates(PDCs) CDMO Service Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Peptide-Drug Conjugates(PDCs) CDMO Service Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Peptide-Drug Conjugates(PDCs) CDMO Service, Headquarters and Area Served
Table 20. Global Key Players of Peptide-Drug Conjugates(PDCs) CDMO Service, Product and Application
Table 21. Global Key Players of Peptide-Drug Conjugates(PDCs) CDMO Service, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Peptide-Drug Conjugates(PDCs) CDMO Service Revenue Market Share by Type (2020-2025)
Table 25. Global Peptide-Drug Conjugates(PDCs) CDMO Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Peptide-Drug Conjugates(PDCs) CDMO Service Revenue Market Share by Type (2026-2031)
Table 27. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Peptide-Drug Conjugates(PDCs) CDMO Service Revenue Market Share by Application (2020-2025)
Table 29. Global Peptide-Drug Conjugates(PDCs) CDMO Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Peptide-Drug Conjugates(PDCs) CDMO Service Revenue Market Share by Application (2026-2031)
Table 31. North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2026-2031) & (US$ Million)
Table 46. WUXIAPP Company Details
Table 47. WUXIAPP Business Overview
Table 48. WUXIAPP Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 49. WUXIAPP Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 50. WUXIAPP Recent Development
Table 51. Medicilon Company Details
Table 52. Medicilon Business Overview
Table 53. Medicilon Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 54. Medicilon Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 55. Medicilon Recent Development
Table 56. Creative Peptides Company Details
Table 57. Creative Peptides Business Overview
Table 58. Creative Peptides Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 59. Creative Peptides Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 60. Creative Peptides Recent Development
Table 61. Peptistar Company Details
Table 62. Peptistar Business Overview
Table 63. Peptistar Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 64. Peptistar Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 65. Peptistar Recent Development
Table 66. BOCSCI Inc Company Details
Table 67. BOCSCI Inc Business Overview
Table 68. BOCSCI Inc Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 69. BOCSCI Inc Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 70. BOCSCI Inc Recent Development
Table 71. HUATENG PHARMA Company Details
Table 72. HUATENG PHARMA Business Overview
Table 73. HUATENG PHARMA Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 74. HUATENG PHARMA Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 75. HUATENG PHARMA Recent Development
Table 76. CPC Scientific Inc Company Details
Table 77. CPC Scientific Inc Business Overview
Table 78. CPC Scientific Inc Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 79. CPC Scientific Inc Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 80. CPC Scientific Inc Recent Development
Table 81. Porton Company Details
Table 82. Porton Business Overview
Table 83. Porton Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 84. Porton Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 85. Porton Recent Development
Table 86. VIVA Biotech Company Details
Table 87. VIVA Biotech Business Overview
Table 88. VIVA Biotech Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 89. VIVA Biotech Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 90. VIVA Biotech Recent Development
Table 91. Taichu Group Company Details
Table 92. Taichu Group Business Overview
Table 93. Taichu Group Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 94. Taichu Group Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 95. Taichu Group Recent Development
Table 96. PharosGen Company Details
Table 97. PharosGen Business Overview
Table 98. PharosGen Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 99. PharosGen Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 100. PharosGen Recent Development
Table 101. CENTER LABORATORIES, INC Company Details
Table 102. CENTER LABORATORIES, INC Business Overview
Table 103. CENTER LABORATORIES, INC Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 104. CENTER LABORATORIES, INC Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 105. CENTER LABORATORIES, INC Recent Development
Table 106. JIUZHOU Pharmaceutical Company Details
Table 107. JIUZHOU Pharmaceutical Business Overview
Table 108. JIUZHOU Pharmaceutical Peptide-Drug Conjugates(PDCs) CDMO Service Product
Table 109. JIUZHOU Pharmaceutical Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025) & (US$ Million)
Table 110. JIUZHOU Pharmaceutical Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Peptide-Drug Conjugates(PDCs) CDMO Service Picture
Figure 2. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Type: 2024 VS 2031
Figure 4. Therapeutic Features
Figure 5. Diagnostic Features
Figure 6. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Application: 2024 VS 2031
Figure 8. SME Pharmaceutical Company Case Studies
Figure 9. Large Pharmaceutical Company Case Studies
Figure 10. Peptide-Drug Conjugates(PDCs) CDMO Service Report Years Considered
Figure 11. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Region: 2024 VS 2031
Figure 14. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Players in 2024
Figure 15. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Peptide-Drug Conjugates(PDCs) CDMO Service Revenue in 2024
Figure 17. North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Country (2020-2031)
Figure 19. United States Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Country (2020-2031)
Figure 23. Germany Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Region (2020-2031)
Figure 31. China Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Country (2020-2031)
Figure 39. Mexico Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Country (2020-2031)
Figure 43. Turkey Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. WUXIAPP Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 47. Medicilon Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 48. Creative Peptides Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 49. Peptistar Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 50. BOCSCI Inc Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 51. HUATENG PHARMA Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 52. CPC Scientific Inc Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 53. Porton Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 54. VIVA Biotech Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 55. Taichu Group Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 56. PharosGen Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 57. CENTER LABORATORIES, INC Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 58. JIUZHOU Pharmaceutical Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232